Dishman Carbogen Amics (NSE:DCAL) Forward PE Ratio: 0.00 (As of Jul. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:DCAL Dishman Carbogen Amics Ltd NSE:DCAL
68 GF Score
Price ₹183.58
GF Value ₹238.30
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Dishman Carbogen Amics Forward PE Ratio?

Dishman Carbogen Amics NSE:DCAL +2.42% 68 Forward PE Ratio is 0.00 as of Jul. 26, 2026. GuruFocus rates NSE:DCAL with a GF Score™ of 68/100 and a GF Value™ of ₹238.30 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 354 Biotechnology companies, Dishman Carbogen Amics ranks worse than 282485.59% on this metric.

Dishman Carbogen Amics's Forward PE Ratio for today is 0.00.

Dishman Carbogen Amics's PE Ratio without NRI for today is 28.96.

Dishman Carbogen Amics's PE Ratio (TTM) for today is 29.64.


Dishman Carbogen Amics  (NSE:DCAL) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Dishman Carbogen Amics Forward PE Ratio Related Terms


Dishman Carbogen Amics Forward PE Ratio Historical Data

* Premium members only.

The historical data trend for Dishman Carbogen Amics's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dishman Carbogen Amics Forward PE Ratio Chart

Dishman Carbogen Amics Annual Data
Trend
Forward PE Ratio

Dishman Carbogen Amics Quarterly Data
Forward PE Ratio

NSE:DCAL vs VRTX, REGN, RVMD: Forward PE Ratio Comparison

For the Biotechnology subindustry, Dishman Carbogen Amics's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dishman Carbogen Amics Forward PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dishman Carbogen Amics's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Dishman Carbogen Amics's Forward PE Ratio falls into.


NSE:DCAL
68GF Score
Dishman Carbogen Amics Ltd NSE:DCAL
Forward PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dishman Carbogen Amics Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Frequently Asked Questions Learn more about Forward PE Ratio →
What does a Forward PE Ratio of 0.00 mean?
Dishman Carbogen Amics (NSE:DCAL) has a Forward PE Ratio of 0.00 as of Jul. 26, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Dishman Carbogen Amics and its competitors. According to the industry distribution chart, Dishman Carbogen Amics ranks #999999 out of 354 companies in the Biotechnology industry.
Is Dishman Carbogen Amics' Forward PE Ratio too high?
Dishman Carbogen Amics' current Forward PE Ratio is 0.00. Based on the distribution chart, Dishman Carbogen Amics ranks #999999 out of 354 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Dishman Carbogen Amics has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dishman Carbogen Amics' Forward PE Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Dishman Carbogen Amics ranks #999999 out of 354 companies for Forward PE Ratio. This places Dishman Carbogen Amics in the lower half of its industry. The industry median Forward PE Ratio is 21.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Biotechnology company?
The median Forward PE Ratio among Biotechnology companies is 21.88, based on 354 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Dishman Carbogen Amics and its competitors. For the Biotechnology industry, the median Forward PE Ratio is 21.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dishman Carbogen Amics's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dishman Carbogen Amics stock overvalued right now?
Based on GuruFocus' analysis, Dishman Carbogen Amics (NSE:DCAL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹238.30, compared to a current price of ₹183.58 — trading 23% below its estimated fair value. The current Forward PE Ratio is 0.00. Dishman Carbogen Amics' overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Dishman Carbogen Amics (NSE:DCAL), the current Forward PE Ratio is 0.00 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dishman Carbogen Amics (NSE:DCAL) Overvalued in 2026?

Based on GuruFocus' analysis, Dishman Carbogen Amics stock appears to be undervalued. The current stock price of ₹183.58 is trading 23% below its estimated GF Value™ of ₹238.30. GuruFocus considers Dishman Carbogen Amics to be Modestly Undervalued.

Key valuation signals for NSE:DCAL:

  • Forward PE Ratio: 0.00
  • GF Value™: ₹238.30 vs. price of ₹183.58 (23% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the NSE:DCAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dishman Carbogen Amics Business Description

Other Exchanges 540701:India
Address Iscon-Bopal Road, Dishman Corporate House, Ambli, Ahmedabad, GJ, IND, 380 058
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.
68GF Score

Get the complete analysis for NSE:DCAL

Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹183.58
Price
₹238.30
GF Value